{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:46:16Z","timestamp":1784317576129,"version":"3.55.0"},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2005,2,2]],"date-time":"2005-02-02T00:00:00Z","timestamp":1107302400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p>To assess the sensitivity of the Swedish surveillance system, four notifiable communicable diseases in Sweden were examined during 1998\u20132002 with the two-sources capture\u2013recapture method, based on parallel clinical and laboratory notifications. The sensitivity (proportion of diagnosed diseases actually being notified) was highest for salmonellosis (99\u00b79%), followed by meningococcal infection (98\u00b77%), and tularaemia (98\u00b75%). For penicillin-resistant pneumococci, introduced as a notifiable disease in 1996, the overall sensitivity was 93\u00b74% \u2013 increasing from 86\u00b75% in 1998 to 98\u00b75% in 2002. The system benefited from parallel reporting, with a sensitivity of clinical and laboratory notifications alone (all diseases combined) of 91\u00b76% and 95\u00b79% respectively. The sensitivity of both clinical and laboratory notifications was markedly higher in counties using the national electronic reporting system, SmiNet. Thus, sensitivity was higher for diseases with a long tradition of reporting, and there is a run-in period after a new disease becomes notifiable.<\/jats:p>","DOI":"10.1017\/s0950268804003632","type":"journal-article","created":{"date-parts":[[2005,5,9]],"date-time":"2005-05-09T10:38:32Z","timestamp":1115635112000},"page":"401-407","source":"Crossref","is-referenced-by-count":56,"title":["Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998\u20132002, assessed by the capture\u2013recapture method"],"prefix":"10.1017","volume":"133","author":[{"given":"A.","family":"JANSSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"ARNEBORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"EKDAHL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2005,2,2]]},"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268804003632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T20:02:01Z","timestamp":1554235321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268804003632\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,2]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0950268804003632"],"URL":"https:\/\/doi.org\/10.1017\/s0950268804003632","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,2]]}}}